We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-1.52%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$131M
AUM Growth
-$120B
Cap. Flow
-$1.55B
Cap. Flow %
-1,177.83%
Top 10 Hldgs %
22.96%
Holding
2,675
New
77
Increased
864
Reduced
681
Closed
85

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$236M
2
HOLX
Hologic
HOLX
+$137M
3
TTD icon
Trade Desk
TTD
+$135M
4
VRSN icon
VeriSign
VRSN
+$127M
5
SKM icon
SK Telecom
SKM
+$127M

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$603M
2
MSFT icon
Microsoft
MSFT
+$241M
3
VTRS icon
Viatris
VTRS
+$233M
4
AAPL icon
Apple
AAPL
+$225M
5
AMZN icon
Amazon
AMZN
+$212M

Sector Composition

Rank Sector Weight
1 Technology 25.32%
2 Financials 12.9%
3 Industrials 12.88%
4 Healthcare 12.52%
5 Consumer Discretionary 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NHC icon
2226
National Healthcare
NHC
$3.53B
$31 ﹤0.01%
442
SRCE icon
2227
1st Source
SRCE
$2.07B
$31 ﹤0.01%
670
TREE icon
2228
LendingTree
TREE
$544M
$31 ﹤0.01%
263
-2,480
-90% -$293K
BCOV
2229
DELISTED
Brightcove, Inc.
BCOV
$31 ﹤0.01%
3,940
NGM
2230
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$31 ﹤0.01%
2,058
DADA
2231
DELISTED
Dada Nexus
DADA
$30 ﹤0.01%
3,340
INO icon
2232
Inovio Pharmaceuticals
INO
$79.8M
$30 ﹤0.01%
698
OMER icon
2233
Omeros
OMER
$709M
$30 ﹤0.01%
4,909
BEAM icon
2234
Beam Therapeutics
BEAM
$2.58B
$29 ﹤0.01%
510
CUE icon
2235
Cue Biopharma
CUE
$135M
$29 ﹤0.01%
200
EPC icon
2236
Edgewell Personal Care
EPC
$1.27B
$29 ﹤0.01%
786
FORR icon
2237
Forrester Research
FORR
$172M
$29 ﹤0.01%
516
NOTV
2238
DELISTED
Inotiv
NOTV
$29 ﹤0.01%
1,099
+258
+31% +$7.25K
PRDO icon
2239
Perdoceo Education
PRDO
$1.9B
$29 ﹤0.01%
2,560
SHOE
2240
Shoe Station Group
SHOE
$395M
$29 ﹤0.01%
980
SFIX
2241
Stitch Fix
SFIX
$478M
$29 ﹤0.01%
2,892
-44,542
-94% -$615K
QTTB icon
2242
Q32 Bio
QTTB
$450M
$29 ﹤0.01%
539
NVTA
2243
DELISTED
Invitae Corporation
NVTA
$29 ﹤0.01%
3,591
-5,145,640
-100% -$51.8M
ENDP
2244
DELISTED
Endo International plc
ENDP
$29 ﹤0.01%
12,559
CTS icon
2245
CTS Corp
CTS
$1.72B
$28 ﹤0.01%
798
ENTA icon
2246
Enanta Pharmaceuticals
ENTA
$372M
$28 ﹤0.01%
398
EXTR icon
2247
Extreme Networks
EXTR
$3.86B
$28 ﹤0.01%
2,289
GVA icon
2248
Granite Construction
GVA
$5.45B
$28 ﹤0.01%
849
MLCO icon
2249
Melco Resorts & Entertainment
MLCO
$2.1B
$28 ﹤0.01%
3,647
PRK icon
2250
Park National Corp
PRK
$3.41B
$28 ﹤0.01%
213

Similar funds

Macquarie Group's Q1 2022 Portfolio in Review

As of Q1 2022, Macquarie Group held 2,675 positions worth $131M, down 100% from $120B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Macquarie Group withdrew a net $1.55B in Q1 2022, closing 85 positions and reducing 681 holdings. Its most notable exit was Great Western Bancorp, Inc., an estimated $139M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

Against the trend, Macquarie Group opened a new position in SK Telecom worth $125K.

  • Macquarie Group's largest Q1 2022 buy was SK Telecom: 4,885,745 shares worth $125K.
  • Macquarie Group added most to Prologis in Q1 2022, an estimated $236M increase.
  • Macquarie Group's biggest Q1 2022 reduction was Cerner Corp, cutting an estimated $603M.
  • Macquarie Group fully exited Great Western Bancorp, Inc. in Q1 2022, selling an estimated $139M.
  • Macquarie Group's ten largest holdings make up 23% of its $131M portfolio in Q1 2022.
  • Macquarie Group opened 77 new positions and closed 85 in Q1 2022.
  • Macquarie Group's portfolio value fell 100% quarter-over-quarter to $131M.

Based on Macquarie Group's 13F filing for Q1 2022, filed 16 May 2022.